Wim van Putten

DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia

María E. Figueroa, Sanne Lugthart, Yushan Li et al. · Cancer Cell · 2010 · 833 citations · Full text

Life Sciences, Molecular Biology, Oncology +12

High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia

Bob Löwenberg, Gert J. Ossenkoppele, Wim van Putten et al. · New England Journal of Medicine · 2009 · 822 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance

Roel G.W. Verhaak, Chantal S. Goudswaard, Wim van Putten et al. · Blood · 2005 · 617 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma

Franck Morschhauser, John Radford, Achiel Van Hoof et al. · Journal of Clinical Oncology · 2008 · 460 citations

Medicine, Oncology, Pharmacotherapy +17

Cytarabine Dose for Acute Myeloid Leukemia

Bob Löwenberg, Thomas Pabst, Edo Vellenga et al. · New England Journal of Medicine · 2011 · 407 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17